CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding CytomX Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 88 | 74 | −14 |
| Shares | 44.6M | 50.7M | +6.14M (+13.8%) |
| Value | $97.1M | $61.9M | −$35.3M (−36.3%) |
New holders (13)
Institutions that held CytomX Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 6,301,983 | $7.72M | 0.00% |
| RTW Investments, LP | 1,200,002 | $1.46M | 0.02% |
| SEI Investments Co | 382,723 | $466.9K | 0.00% |
| Candriam Luxembourg S.C.A. | 210,027 | $256.2K | 0.00% |
| Creative Planning | 107,000 | $130.5K | 0.00% |
| Stifel Financial Corp | 47,100 | $57.5K | 0.00% |
| Invesco Ltd. | 23,094 | $28.2K | 0.00% |
| Tower Research Capital LLC (TRC) | 17,039 | $20.8K | 0.00% |
| Nierenberg Investment Management Company, Inc. | 12,555 | $15.3K | 0.01% |
| Ikarian Capital, LLC | 8,924 | $10.9K | 0.00% |
| Advisor Group Holdings, Inc. | 900 | $1.10K | 0.00% |
| Innealta Capital, LLC | 2 | $2 | 0.00% |
| Royal Bank of Canada | 248 | $0 | 0.00% |
Sold out (27)
Institutions that held CytomX Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.